Search research articles
Contact Us
Filters
Showing results (51-60 of 406) with videos related to
Page
of 41
Sort By:
AIDS (London, England)
|
February 16, 2007
Two versus three-class antiretroviral therapy in antiretroviral-naive patients in different time periods of the HAART era
Patrick Taffé, Heiner C Bucher, Markus Flepp, et al.
Sozial- Und Praventivmedizin
|
January 1, 1997
[HIV prevention in Turkish immigrants in a general internal medicine outpatient service]
H C Bucher, T Eser, M Weinbacher, et al.
The Cochrane Database of Systematic Reviews
|
July 21, 2006
Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV-infection
M Briel, H C Bucher, R Boscacci, et al.
The Journal of Urology
|
January 11, 1975
Genitourinary aspects of disseminated coccidioidomycosis
W T Conner, G W Drach, W C Bucher
Neurosurgical Review
|
May 19, 2004
Demographics and prevalent risk factors of chronic subdural haematoma: results of a large single-center cohort study
H Baechli, A Nordmann, H C Bucher, et al.
The American Journal of Medicine
|
March 15, 2002
N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials
Heiner C Bucher, Peter Hengstler, Christian Schindler, et al.
BMC Infectious Diseases
|
November 8, 2005
Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV infection: a meta-analysis of randomised controlled trials
Matthias Briel, Remy Boscacci, Hansjakob Furrer, et al.
BMC Medical Informatics and Decision Making
|
January 2, 2009
Accuracy of drug advertisements in medical journals under new law regulating the marketing of pharmaceutical products in Switzerland
Macarena Gonzalez Santiago, Heiner C Bucher, Alain J Nordmann
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 18, 2000
Discontinuation of secondary prophylaxis for toxoplasmic encephalitis in human immunodeficiency virus infection after immune restoration with highly active antiretroviral therapy
A C Guex, A J Radziwill, H C Bucher
Journal of HIV Therapy
|
August 15, 2001
The use of lipid-lowering agents in HIV-infected patients
F Meienberg, E Battegay, H C Bucher, et al.
Page
of 41
Search research articles
Search
Showing results (51-60 of 406) with videos related to
Sort By:
Page
of 41
AIDS (London, England)
|
February 16, 2007
Two versus three-class antiretroviral therapy in antiretroviral-naive patients in different time periods of the HAART era
Patrick Taffé, Heiner C Bucher, Markus Flepp, et al.
Sozial- Und Praventivmedizin
|
January 1, 1997
[HIV prevention in Turkish immigrants in a general internal medicine outpatient service]
H C Bucher, T Eser, M Weinbacher, et al.
The Cochrane Database of Systematic Reviews
|
July 21, 2006
Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV-infection
M Briel, H C Bucher, R Boscacci, et al.
The Journal of Urology
|
January 11, 1975
Genitourinary aspects of disseminated coccidioidomycosis
W T Conner, G W Drach, W C Bucher
Neurosurgical Review
|
May 19, 2004
Demographics and prevalent risk factors of chronic subdural haematoma: results of a large single-center cohort study
H Baechli, A Nordmann, H C Bucher, et al.
The American Journal of Medicine
|
March 15, 2002
N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials
Heiner C Bucher, Peter Hengstler, Christian Schindler, et al.
BMC Infectious Diseases
|
November 8, 2005
Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV infection: a meta-analysis of randomised controlled trials
Matthias Briel, Remy Boscacci, Hansjakob Furrer, et al.
BMC Medical Informatics and Decision Making
|
January 2, 2009
Accuracy of drug advertisements in medical journals under new law regulating the marketing of pharmaceutical products in Switzerland
Macarena Gonzalez Santiago, Heiner C Bucher, Alain J Nordmann
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 18, 2000
Discontinuation of secondary prophylaxis for toxoplasmic encephalitis in human immunodeficiency virus infection after immune restoration with highly active antiretroviral therapy
A C Guex, A J Radziwill, H C Bucher
Journal of HIV Therapy
|
August 15, 2001
The use of lipid-lowering agents in HIV-infected patients
F Meienberg, E Battegay, H C Bucher, et al.
Page
of 41